Bionow | News

AMBLor® prognostic melanoma biomarker receives UKCA mark

Sep 3rd 2024

AMBLor is a groundbreaking histopathological biomarker test for the personal identification of early-stage melanomas at low risk of progression, post staging diagnosis.

New spin-out OCUWELL set to transform corneal care

Jul 17th 2024

A University of Liverpool spin-out company OCUWELL has developed novel corneal assessment technology that has the potential to transform eye care delivery.

Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit fo...

Sep 6th 2023

Offering clinical labs in APAC and Middle East cost-efficient, bench-top robotic cell-free DNA extraction workstation and reagents for Yourgene’s Sage 32 NIPT Workflow

Yourgene Health Presents Data Demonstrating Successful Fetal Fraction Enrichment...

Jun 20th 2023

Extended EDTA blood tube storage offers improved flexibility and cost-saving in non-invasive prenatal testing (NIPT) workflows

North east innovation lab celebrates two year anniversary supporting the develop...

Jan 9th 2023

Lab supports developers with testing and improving their technologies, which includes conducting independent performance evaluations and validations for new and emerging diagnostics; methodo...

Academics and industry come together for Tools for Improving Clinical Diagnostic...

Dec 9th 2022

Diagnostics experts gathered together at the joint session on 7th December, partnered by Bionow and the University of Durham and hosted at the university’s Calman Learning Centre, to showc...

QuantuMDx and Menarini Announce an Exclusive Distribution Agreement for the Q-P...

Nov 2nd 2022

Agreement will initially cover the UK and France with potential to expand to other European countries and worldwide

Product in Focus: Ristocetin CoFactor Assay Kit

Mar 31st 2022

This week, the product in focus is the Hart Biologicals Ristocetin co-factor assay kit. The kit is intended for the quantification of von Willebrand factor activity through the reflective as...

Contract Manufacturing: Your Concept

Mar 17th 2022

Take a look at our Contract Manufacturing services. You may know us as a reagent manufacturer, but did you know that we also offer services in contract manufacturing? As a leader in haemosta...

Technology transfer agreement for iiCON validated COVID test will see product us...

Jul 26th 2021

A rapid COVID-19 antigen test, validated through the Infection Innovation Consortium (iiCON), will be used to deliver large-scale testing across Africa as part of a major FIND and UNITAID pr...

Exec Insight: Jonathan O'Halloran talks about the growth and development of Quan...

Jun 28th 2021

An interview with Jonathan O'Halloran, CEO of QuantuMDx

Brightline Diagnostics combines novel technologies in a new lateral flow test an...

Dec 4th 2020

Two highly innovative UK companies, Stream Bio and Chelsea Technologies, have formed a joint venture, Brightline Diagnostics (DX), combining their unique technologies to develop a next-gener...

News